Spinal_muscular_atrophy_with_lower_extremity_predominance_2A

Spinal muscular atrophy with lower extremity predominance 2A

Spinal muscular atrophy with lower extremity predominance 2A

Rare genetic disease


Spinal muscular atrophy with lower extremity predominance 2A (SMALED2A) is a rare neuromuscular disorder characterised by muscle weakness predominantly in legs. The disorder is usually diagnosed shortly after birth; affected children have a delayed motor development, waddling gait, difficulties walking, sometimes develop spasticity.[1][2] Sensation, swallowing and cognitive development are not affected. The disorder is slowly progressive throughout the lifetime.[1]

Quick Facts Other names, Specialty ...

The disease is caused by a mutation in the BICD2 gene and is passed on in an autosomal dominant manner.[1]

There is no known cure for SMALED2A.[citation needed]

See also


References

  1. Frasquet, M.; Camacho, A.; Vílchez, R.; Argente-Escrig, H.; Millet, E.; Vázquez-Costa, J. F.; Silla, R.; Sánchez-Monteagudo, A.; Vílchez, J. J.; Espinós, C.; Lupo, V. (2020). "Clinical spectrum of BICD2 mutations". European Journal of Neurology. 27 (7): 1327–1335. doi:10.1111/ene.14173. ISSN 1351-5101. PMID 32056343. S2CID 211110838.

Share this article:

This article uses material from the Wikipedia article Spinal_muscular_atrophy_with_lower_extremity_predominance_2A, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.